{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:07:22Z","timestamp":1779098842540,"version":"3.51.4"},"reference-count":53,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,4,3]]},"DOI":"10.1080\/14740338.2022.2120607","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T10:00:53Z","timestamp":1661940053000},"page":"343-349","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom"],"prefix":"10.1080","volume":"22","author":[{"given":"Matilde","family":"Otero-Losada","sequence":"first","affiliation":[{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, Universidad Abierta Interamericana-Centro de Altos Estudios en Ciencias Humanas y de La Salud, UAI-CAECIHS CONICET, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[{"name":"Flinders University, Bedford Park, Australia"},{"name":"Vaxine, Bedford Park, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Alami","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada"},{"name":"Risk Sciences International, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Crispo","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Carleton University, Ottawa, Ontario, Canada"},{"name":"Human Sciences Division, Northern Ontario School of Medicine, Sudbury, Ontario, Canada"},{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5623-0874","authenticated-orcid":false,"given":"Donald","family":"Mattison","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada"},{"name":"Risk Sciences International, Ottawa, Ontario, Canada"},{"name":"Arnold School of Public Health, University of South Carolina, Columbia, Ontario, USA"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Capani","sequence":"additional","affiliation":[{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, Universidad Abierta Interamericana-Centro de Altos Estudios en Ciencias Humanas y de La Salud, UAI-CAECIHS CONICET, Buenos Aires, Argentina"},{"name":"Facultad de Ciencias de la Salud, Universidad Aut\u00f3noma de Chile, Santiago de Chile, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Goetz","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Krewski","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, Ottawa, Ontario, Canada"},{"name":"Risk Sciences International, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Perez-Lloret","sequence":"additional","affiliation":[{"name":"Observatorio de Salud P\u00fablica, Pontificia Universidad Cat\u00f3lica Argentina, Buenos Aires, Argentina"},{"name":"Department of Physiology, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8565"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00432-3"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27203"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107763"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.09.002"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0475-9"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.17226\/10822"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1546"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.032"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14407"},{"key":"e_1_3_7_16_1","unstructured":"Safety platform for emergency vACcines. D2.3 priority list of adverse events of special interest: COVID-19. https:\/\/brightoncollaboration.us\/wp-content\/uploads\/2020\/06\/SPEAC_D2.3_V2.0_COVID-19_20200525_public.pdf. cited 2022 June 11."},{"issue":"1435","key":"e_1_3_7_17_1","article-title":"Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study","volume":"373","author":"Li X","year":"2021","unstructured":"Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373(1435)","journal-title":"BMJ"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.10.030"},{"key":"e_1_3_7_20_1","unstructured":"Medicines & Healthcare products Regulatory Agency. Coronavirus vaccine - weekly summary of yellow card reporting - GOV.UK. 2021. https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting. cited 2021 July 11."},{"key":"e_1_3_7_21_1","article-title":"Medical dictionary for regulatory activities (MedDRA\u00ae)","author":"Brown E","year":"2007","unstructured":"Brown E. Medical dictionary for regulatory activities (MedDRA\u00ae), Pharmacovigilance, 2007;Second Edition","journal-title":"Pharmacovigilance"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01968.x"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050722"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200404000-00002"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730100-00007"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00076-1"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.1266"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2021.0187"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05523-5"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1954826"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327027"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05467-w"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7032e4"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26218"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01556-7"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243829"},{"issue":"6","key":"e_1_3_7_39_1","first-page":"e15935","article-title":"Bell\u2019s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine","volume":"13","author":"Iftikhar H","year":"2021","unstructured":"Iftikhar H, Noor SMU, Masood M, et al. Bell\u2019s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus. 2021;13(6):e15935.","journal-title":"Cureus"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2016-001383"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.1259"},{"key":"e_1_3_7_42_1","first-page":"1","article-title":"Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"3099","author":"Wan EYF","year":"2021","unstructured":"Wan EYF, Chui CSL, Lai FTT, et al. Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2021;3099:1\u20139.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_7_43_1","first-page":"100098","article-title":"Transient akathisia after the SARS-Cov-2 vaccine","volume":"4","author":"Salinas MR","year":"2021","unstructured":"Salinas MR, Dieppa M. Transient akathisia after the SARS-Cov-2 vaccine. Clin Park Relat Disord. 2021;4:100098.","journal-title":"Clin Park Relat Disord"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870070213"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.2.258"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.1042"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.595"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00386"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00995"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1264"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327000"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060556"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102685"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1955101"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15029"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2022.2120607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T15:56:11Z","timestamp":1726588571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2022.2120607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"alternative-id":["10.1080\/14740338.2022.2120607"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2022.2120607","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.28.21264245","asserted-by":"object"}]},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}